These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 20200558)

  • 21. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
    Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
    Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
    Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance.
    McNamara S; Wang H; Hanna N; Miller WH
    Mol Cell Biol; 2008 Mar; 28(6):2066-77. PubMed ID: 18212063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.
    Nichol JN; Galbraith MD; Kleinman CL; Espinosa JM; Miller WH
    Cell Rep; 2016 Mar; 14(12):2938-49. PubMed ID: 26997274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoid resistance in leukemic cells.
    Kizaki M; Ueno H; Matsushita H; Takayama N; Muto A; Awaya N; Ikeda Y
    Leuk Lymphoma; 1997 May; 25(5-6):427-34. PubMed ID: 9250812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells.
    Chelbi-Alix MK; Pelicano L
    Leukemia; 1999 Aug; 13(8):1167-74. PubMed ID: 10450744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transcriptomics and proteomics in studies of induced differentiation of leukemia cells].
    Novikova SE; Zgoda VG
    Biomed Khim; 2015; 61(5):529-44. PubMed ID: 26539862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TOP2B's contributions to transcription.
    Austin CA; Cowell IG; Khazeem MM; Lok D; Ng HT
    Biochem Soc Trans; 2021 Dec; 49(6):2483-2493. PubMed ID: 34747992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting TOP2B-related phenotypes: Three new cases and literature review.
    Çepni E; Börklü E; Avcı Ş; Kalaycı T; Eraslan S; Kayserili H
    Clin Genet; 2023 Aug; 104(2):251-258. PubMed ID: 37068767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prevailing Role of Topoisomerase 2 Beta and its Associated Genes in Neurons.
    Neha S ; Dholaniya PS
    Mol Neurobiol; 2021 Dec; 58(12):6443-6459. PubMed ID: 34546528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting TOP2B as a vulnerability in aging and aging-related diseases.
    Zhu M; Li H; Zheng Y; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167044. PubMed ID: 38296114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting PKC delta-mediated topoisomerase II beta overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line.
    McNamara S; Nichol JN; Wang H; Miller WH
    Leukemia; 2010 Apr; 24(4):729-39. PubMed ID: 20200558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review).
    Kizaki M; Fukuchi Y; Ikeda Y
    Int J Mol Med; 1999 Oct; 4(4):359-64. PubMed ID: 10493975
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.